Skip to main content

Table 2 Description of medical context and infectious disease

From: Acute kidney injury during daptomycin versus vancomycin treatment in cardiovascular critically ill patients: a propensity score matched analysis

Characteristics DAP (N = 28) VAN (N = 44) p
Reason for ICU admission    .004
 Cardiac surgery, n (%) 15 (53.6) 26 (59.1)
 Vascular surgery, n (%) 2 (7.1) 14 (31.8)
 Interventional cardiology or short-term mechanical circulatory support, n (%) 9 (32.1) 4 (9.4)
 Mediastinitis, n (%) 2 (7.1) 0 (0)
Primary infectious disease    .045
 Infective endocarditis, n (%) 8 (28.6) 15 (34.1)
 Vascular graft infection, n (%) 2 (7.1) 12 (27.3)
 VAD infection, n (%) 4 (14.3) 0 (0)
 Surgical site infection, n (%) 5 (17.9) 6 (13.6)
 Catheter-related infection, n (%) 5 (17.9) 4 (9.1)
 Miscellaneous, n (%) 4 (14.3) 7 (15.9)
Microbiological identification    .002
 MSSA, n (%) 7 (25.0) 4 (9.1)
 MRSA, n (%) 4 (14.3) 3 (6.8)
 CNS, n (%) 13 (46.4) 9 (20.5)
 Enterococcus, n (%) 1 (3.6) 4 (9.1)
 Other Gram-positive cocci, n (%) 1 (3.6) 6 (13.6)
 Other strains or non-documented, n (%) 2 (7.1) 18 (40.1)
  1. P-values for Fisher exact test. DAP daptomycin, VAN vancomycin, ICU intensive care unit, VAD ventricular assist device, MSSA methicillin-susceptible Staphylococcus aureus, MRSA methicillin-resistant Staphylococcus aureus, CNS coagulase negative staphylococci